COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2017

Dec 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-12-08

Reporting Person: Longitude Capital Partners, LLC (10% Owner)
Reporting Person: Tammenoms Bakker Juliet (10% Owner)
Reporting Person: ENRIGHT PATRICK G (10% Owner)
Reporting Person: Longitude Capital Associates, L.P. (10% Owner)
Reporting Person: Longitude Venture Partners L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-08	Common Stock	S	980350	$17.34	Disposed	2276222	Indirect
2017-12-08	Common Stock	S	19650	$17.34	Disposed	45620	Indirect

Footnotes

F1: This report is filed jointly by Longitude Capital Partners, LLC ("LCP"), Longitude Venture Partners, L.P. ("LVP"), Longitude Capital Associates, L.P. ("LCA"), Patrick G. Enright ("Enright") and Juliet Tammenoms Bakker ("Bakker"). LCP is the general partner of LVP and LCA, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of Enright and Bakker is a managing member of LCP, has the power to vote and dispose of the securities of the Issuer held by each of LVP and LCA, and may be deemed to have beneficial ownership of such securities. Each of LCP, Enright and Bakker disclaims beneficial ownership of the securities of the Issuer held by LVP and LCA except to the extent of their respective pecuniary interest therein.